Edward José De Oliveira - Infectious Diseases

Author Information

Edward José De Oliveira is a researcher affiliated with the Instituto René Rachou-Oswaldo Cruz Foundation, located in Belo Horizonte, Brazil. His work is primarily focused on clinical research and public policy in the field of infectious and parasitic diseases. Through his research, he contributes significantly to the understanding and development of diagnostic and therapeutic strategies for various infectious diseases.

Research Contributions

Edward José De Oliveira has made substantial contributions to the field of infectious diseases, with a particular focus on leishmaniasis and schistosomiasis. His research includes the development of diagnostic tools and biomarkers for these diseases, as evidenced by his work on immunological biomarkers for Leishmania infections and real-time PCR assays for Schistosoma mansoni. Additionally, his studies address the immune response mechanisms, such as the expression of NLRP3 inflammasome in leprosy and the role of oxidative stress in Leishmania braziliensis. His recent work also explores the differential diagnosis of pulmonary hemorrhage in dengue and its distinction from acute viral respiratory syndromes, including COVID-19.

Aliases

Edward José De Oliveira is known by several aliases, including Edward José De Oliveira, E. J. Oliveira, Edward J. Oliveira, Edward José Oliveira, and Edward Oliveira.

Publication and Citation Metrics

Metric	Value
Total Citations	698
H-index	16
Total Publications	54

Publications:

Pulmonary hemorrhage in dengue: differential diagnosis with acute viral respiratory syndromes including COVID-19

DOI: 10.1590/S1678-9946202264013

Year: 2022

Anti-mitochondrial Tryparedoxin Peroxidase Monoclonal Antibody-Based Immunohistochemistry for Diagnosis of Cutaneous Leishmaniasis

DOI: 10.3389/fmicb.2021.790906

Year: 2021

Potential antigenic targets used in immunological tests for diagnosis of tegumentary leishmaniasis: A systematic review

DOI: 10.1371/journal.pone.0251956

Year: 2021

Prospection of immunological biomarkers for characterization and monitoring of asymptomatic Leishmania (Leishmania) infantum infection

DOI: 10.1017/S0031182020000852

Year: 2020

The heterologous expression of Escherichia coli MutT enzyme is involved in the protection against oxidative stress in Leishmania braziliensis

DOI: 10.1590/0074-02760190469

Year: 2020

Laboratorial algorithm for serological diagnosis of visceral leishmaniasis using rK39-ICT, DAT-LPC and FC-Simplex IgG1.

DOI: 10.1016/j.jim.2020.112765

Year: 2020

Leishmania infantum induces high phagocytic capacity and intracellular nitric oxide production by human proinflammatory monocyte

DOI: 10.1590/0074-02760190408

Year: 2020

A Real-Time PCR Assay for the Diagnosis of Intestinal Schistosomiasis and Cure Assessment After the Treatment of Individuals With Low Parasite Burden

DOI: 10.3389/fimmu.2020.620417

Year: 2020

Accuracy of real-time polymerase chain reaction to detect Schistosoma mansoni – infected individuals from an endemic area with low parasite loads

DOI: 10.1017/S003118202000089X

Year: 2020

Expression of NLRP3 inflammasome in leprosy indicates immune evasion of Mycobacterium leprae

DOI: 10.1590/0074-02760190324

Year: 2020

What are the Symptoms of Salmonella Infection?

What are the Recent Advances in Serological Testing?

Are there specific populations at higher risk for drug interactions?

Can Flaviviridae infections be prevented?

What are Antibiotics?

What is Microcephaly?

What is Hand, Foot, and Mouth Disease?

What are the Treatment Options for Strep Throat?

Is there a Vaccine for West Nile Virus?

What Could Be Causing Weight Loss?

Partnered Content Networks

Relevant Topics